Cagrilintide + Semaglutide Blend
Documentation & standards
- How to Read a Peptide Certificate of Analysis (COA)
- Peptide Storage and Handling: Temperature, Light and Stability
- Research-Use-Only Compliance: What the Label Obligates
CagriSema research blend combining long-acting amylin-analog and GLP-1-receptor pathways for controlled laboratory study.
Mix and match any items — discount applies automatically at checkout.
Reminder email when it's time to reorder. No card on file. Cancel anytime from your account — or email support@aresresearchlab.com.
Earn 84 loyalty points on this purchase · 100 pts = $5 off
Create a Research Account to unlock full batch data, COAs, and priority releases.
Intended strictly for controlled laboratory receptor and pathway research.
Cagrilintide + Semaglutide Blend research
Cagrilintide + Semaglutide Blend, also described in research literature as CagriSema, combines an amylin analog with a GLP-1 receptor agonist analog in one laboratory material.
This page owns blend-specific research intent: amylin versus GLP-1 receptor pathways, dual-pathway assay planning, component controls, and combined-study design. It does not represent the standalone Cagrilintide material.
For isolated amylin-analog research, see standalone Cagrilintide.
Blend verification and batch lookup
No blend-specific analytical report is currently represented as being on file, and the standalone Cagrilintide record is not used as evidence for this blend. Search the unit’s identifier in the public batch lookup to see which documentation is available. The transparency page explains general verification standards without turning them into a result for a specific blend batch.
Cagrilintide + Semaglutide Blend specifications
| Material | Cagrilintide + Semaglutide research blend |
|---|---|
| Research name | CagriSema |
| Components | Long-acting amylin analog + GLP-1 receptor agonist analog |
| Research focus | Amylin- and GLP-1-receptor pathway interaction and combined assay design |
| Purity specification | ≥99% |
| Physical form | Lyophilized blend in a sealed glass vial |
| Available vial sizes | 5 mg and 10 mg |
| Testing | General batch-documentation lookup available; no blend-specific report represented as on file |
| Storage | Refrigerated, dry, and protected from light; follow batch documentation |
| Intended scope | Controlled laboratory research only — not for human or veterinary use |
CagriSema blend research questions
+What is the Cagrilintide + Semaglutide blend?
It is a combined laboratory research material containing a long-acting amylin analog and a GLP-1 receptor agonist analog, sometimes described in research literature as CagriSema.
+Which pathways does the blend represent?
The blend supports controlled study of amylin-receptor and GLP-1-receptor signalling within one material system, including pathway interaction and assay-design questions.
+Is the blend the same as standalone Cagrilintide?
No. Standalone Cagrilintide isolates the amylin-analog component, while this listing contains both Cagrilintide and Semaglutide and has separate batch documentation.
+Is a blend-specific analytical report on file?
No blend-specific report is currently represented as being on file. Use the public batch lookup to see which documentation is available for a specific unit; general verification standards are not a blend-batch result.
+What purity specification applies to the blend?
The listed purity specification is ≥99%. Confirm any batch-specific result through the documentation associated with the identifier on the material received.
+What vial sizes are available?
The Cagrilintide + Semaglutide blend is offered as sealed lyophilized research material in 5 mg and 10 mg vial sizes. Current offers appear on this page.
Read the Cagrilintide + Semaglutide Blend research
A laboratory research overview of Cagrilintide identity, long-acting amylin-analog design, receptor complexes, and analytical study considerations.
Read article →A receptor-level guide to Cagrilintide, calcitonin-receptor and RAMP complexes, ligand-response measurements, and experimental controls.
Read article →A laboratory comparison of amylin-receptor and GLP-1-receptor signaling, with controls for combined CagriSema research designs.
Read article →Researcher Reviews
Sign in with the account that placed your order to leave a verified review.
Ask the Lab
No public questions yet — be the first to ask.